Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
AbCellera Biologics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
ABCL
Nasdaq
8731
https://www.abcellera.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for AbCellera Biologics Inc
Billionaire Investor Stan Druckenmiller and Insiders Are Piling Into These 11 Stocks
- Mar 26th, 2024 9:25 pm
AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024
- Mar 19th, 2024 8:05 pm
AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions
- Mar 11th, 2024 1:00 pm
AbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024
- Mar 5th, 2024 9:30 pm
After losing 38% in the past year, AbCellera Biologics Inc. (NASDAQ:ABCL) institutional owners must be relieved by the recent gain
- Feb 29th, 2024 11:27 am
3 Highly Rated Biotech Stocks to Buy for 300% Gains
- Feb 26th, 2024 11:55 am
AbCellera Announces Resignation of Board Member
- Feb 23rd, 2024 9:30 pm
AbCellera to Present at Upcoming Investor Conferences in March
- Feb 23rd, 2024 1:15 am
AbCellera Biologics Inc. (NASDAQ:ABCL) Q4 2023 Earnings Call Transcript
- Feb 21st, 2024 2:22 pm
Q4 2023 Abcellera Biologics Inc Earnings Call
- Feb 21st, 2024 12:09 pm
AbCellera Biologics (ABCL) Q4 2023 Earnings Call Transcript
- Feb 21st, 2024 4:00 am
AbCellera Biologics Inc. (ABCL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
- Feb 21st, 2024 12:00 am
AbCellera Biologics Inc (ABCL) Faces Net Loss in FY 2023 Amid Strategic Shifts
- Feb 20th, 2024 9:57 pm
AbCellera Reports Full Year 2023 Business Results
- Feb 20th, 2024 9:05 pm
Techne (TECH) Q2 Earnings and Revenues Lag Estimates
- Feb 1st, 2024 12:40 pm
Baillie Gifford Adjusts Stake in AbCellera Biologics Inc
- Jan 30th, 2024 6:02 pm
AbCellera to Report Full Year 2023 Financial Results on February 20, 2024
- Jan 23rd, 2024 9:05 pm
3 Growth Stocks That Could Go Parabolic in 2024
- Jan 15th, 2024 2:30 pm
Is AbCellera Biologics (ABCL) Outperforming Other Medical Stocks This Year?
- Jan 3rd, 2024 2:40 pm
AbCellera to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024
- Dec 20th, 2023 9:05 pm
Scroll